Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | 0.0065 | 1 |
mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.00096 | 1 |
mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.00061 | 1 |
mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |